World Journal of Gastroenterology
搜索
World Journal of Gastroenterology
2022年27期
浏览往期
订阅
目录
REVIEW
Hepatitis B and circadian rhythm of the liver
Tumor microenvironment in pancreatic ductal adenocarcinoma:Implications in immunotherapy
Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease
MINIREVIEWS
Application of intravoxel incoherent motion diffusion-weighted imaging in hepatocellular carcinoma
Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy
Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy
Interventional strategies in infected necrotizing pancreatitis:Indications, timing, and outcomes
Artificial intelligence in liver ultrasound
Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
ORIGINAL ARTICLE
Accumulation of poly (adenosine diphosphate-ribose) by sustained supply of calcium inducing mitochondrial stress in pancreatic cancer cells
RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma
Associations of gut microbiota with dyslipidemia based on sex differences in subjects from Northwestern China
Prognostic significance of hemoglobin, albumin, lymphocyte,platelet in gastrointestinal stromal tumors: A propensity matched retrospective cohort study
Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis
Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
SYSTEMATIC REVIEWS
Percutaneous transhepatic cholangiography vs endoscopic ultrasound-guided biliary drainage: A systematic review
CASE REPORT
Isolated gastric variceal bleeding related to non-cirrhotic portal hypertension following oxaliplatin-based chemotherapy: A case report
LETTER TO THE EDITOR
Hepatitis B core-related antigen: Are we near a treatment endpoint?